First human tests begin for new fungal infection pill
NCT ID NCT02957929
Summary
This early-stage study tested APX001, a potential new oral medication for fungal infections, in healthy volunteers. The main goal was to check if the drug is safe and to understand how the body absorbs and processes it. Researchers also looked at whether food affects the drug and if it interacts with other common medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PRA Health Sciences
Groningen, Netherlands
-
PRA Health Sciences (PRA) - Early Development Services (EDS)
Groningen, 9728 NZ, Netherlands
Conditions
Explore the condition pages connected to this study.